Clinical review: the use of vaptans in clinical endocrinology.

@article{Peri2013ClinicalRT,
  title={Clinical review: the use of vaptans in clinical endocrinology.},
  author={Alessandro Peri},
  journal={The Journal of clinical endocrinology and metabolism},
  year={2013},
  volume={98 4},
  pages={
          1321-32
        }
}
CONTEXT Hyponatremia is the most common electrolyte disorder encountered in clinical practice and represents a clinical, social, and economic burden. Conventional treatments of hyponatremia present some pitfalls, such as suboptimal efficacy, risk of overly rapid correction, and adverse effects. Vasopressin receptor antagonists, known as vaptans, represent a new and interesting class of drugs for the treatment of the euvolemic and hypervolemic forms of hyponatremia. EVIDENCE ACQUISITION This… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 25 CITATIONS

Disorders of sodium and water balance.

  • Emergency medicine clinics of North America
  • 2014
VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Textbook of Neuroanesthesia and Neurocritical Care

  • Springer Singapore
  • 2019
VIEW 3 EXCERPTS
CITES BACKGROUND

Efficiency of Single Dose of Tolvaptan Treatment During the Triphasic Episode After Surgery for Craniopharyngioma.

  • Journal of clinical research in pediatric endocrinology
  • 2018
VIEW 2 EXCERPTS
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 102 REFERENCES

Hyponatremia treatment guidelines 2007: expert panel recommendations.

  • The Clinical biochemist. Reviews
  • 2009
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL

Diabete insipido ed opoterapia

F. Farini
  • Gazz Osped Clin
  • 2012

Similar Papers

Loading similar papers…